Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | XIAP | P98170 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31557865 | 1.00 | GABRA1 (0.43) | GABRA1GABRB2CFTRGPR84XIAP | |
| SCHEMBL25141527 | 0.80 | GABRA1 (0.47) | GABRA1GABRB2CFTR | |
| SCHEMBL27707617 | 0.78 | GPR84 (0.37) | CFTRGPR84 | |
| SCHEMBL23527437 | 0.75 | GABRA1 (0.62) | GABRA1GABRB2 | |
| SCHEMBL2083517 | 0.75 | GABRA1 (0.44) | GABRA1GABRB2 | |
| SCHEMBL7721018 | 0.74 | GABRA1 (0.38) | GABRA1GABRB2 | |
| SCHEMBL432648 | 0.73 | GABRA1 (0.40) | GABRA1GABRB2GPR84 | |
| SCHEMBL7756163 | 0.72 | XIAP (0.36) | GPR84XIAP | |
| SCHEMBL5800459 | 0.71 | CYP1A2 (0.48) | — | |
| SCHEMBL331127 | 0.69 | GABRA1 (0.54) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250133952-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-04-24 | — | — | US | disclosed |
| US-12262630-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-03-25 | — | — | US | disclosed |
| EP-4294158-A2 | USE OF AN ANCILLARY LIGAND IN A PHOSPHORESCENT METAL COMPLEX COMPOUND | Universal Display Corporation (US) | 2023-12-20 | — | — | EP | disclosed |
| EP-3981776-B1 | USE OF AN ANCILLARY LIGAND IN A PHOSPHORESCENT METAL COMPLEX COMPOUND | UNIVERSAL DISPLAY CORP (US) | 2023-11-15 | — | — | EP | disclosed |
| US-20230309373-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-20230200207-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230148324-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230132589-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| EP-3981776-A1 | USE OF AN ANCILLARY LIGAND IN A PHOSPHORESCENT METAL COMPLEX COMPOUND | Universal Display Corporation (US) | 2022-04-13 | — | — | EP | disclosed |
| EP-3632921-B1 | USE OF AN ANCILLARY LIGAND IN A PHOSPHORESCENT METAL COMPLEX COMPOUND | UNIVERSAL DISPLAY CORP (US) | 2021-12-08 | — | — | EP | disclosed |
| US-20190071461-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-07 | — | — | US | disclosed |
| US-10199581-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2019-02-05 | — | — | US | disclosed |
| EP-3333174-A1 | ANCILLARY LIGANDS FOR ORGANOMETALLIC COMPLEXES | Universal Display Corporation (US) | 2018-06-13 | — | — | EP | disclosed |
| EP-2821410-B1 | Ancillary ligands for organometallic complexes | UNIVERSAL DISPLAY CORP (US) | 2018-01-31 | — | — | EP | disclosed |
| EP-2821410-B1 | Ancillary ligands for organometallic complexes | UNIVERSAL DISPLAY CORP (US) | 2018-01-31 | — | — | EP | disclosed |
| CN-104277075-A | Ancillary ligands for organometallic complexes and devices and formulations including the same | UNIVERSAL DISPLAY CORP | 2015-01-14 | — | — | CN | disclosed |
| EP-2821410-A2 | Ancillary ligands for organometallic complexes | Universal Display Corporation (US) | 2015-01-07 | — | — | EP | disclosed |
| US-20150001472-A1 | ANCILLARY LIGANDS FOR ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION | 2015-01-01 | — | — | US | disclosed |
| US-20150001472-A1 | ANCILLARY LIGANDS FOR ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION | 2015-01-01 | — | — | US | disclosed |
| US-20150001472-A1 | ANCILLARY LIGANDS FOR ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION | 2015-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190071461-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, AP1M1, EPCAM | GABRA1 2881/4885GABRB2 3622/4885CFTR 3926/4885 |
| US-12262630-B2 | Organic electroluminescent materials and devices | L1CAM, AP1M1, EPCAM | GABRA1 2881/4885GABRB2 3622/4885CFTR 3926/4885 |
| US-20230132589-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | PPOX, PER2, CRY1 | GABRA1 3329/4885GABRB2 3335/4885CFTR 4764/4885 |
| US-10199581-B2 | Organic electroluminescent materials and devices | L1CAM, AP1M1, EPCAM | GABRA1 2881/4885GABRB2 3622/4885CFTR 3926/4885 |
| US-20250133952-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, AP1M1, EPCAM | GABRA1 2881/4885GABRB2 3622/4885CFTR 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.